Literature DB >> 1244447

Technetium-99m-human serum albumin: evaluation of a commercially produced kit.

R J Callahan, K A McKusick, M Lamson, F P Castronovo, M S Potsaid.   

Abstract

Results are reported on the use of a commercial kit for the labeling of human serum albumin with 99mTc. One-hour blood levels obtained in 20 subjects undergoing gated cardiac imaging were found to be 46.0 +/- 10.5% (s.d.) of the administered dose. The highest labeling efficiencies (94.2 +/- 9.3%) were obtained when human serum albumin 25% (salt-poor) was used. Satisfactory nuclear cardiac ventriculographic images were obtained in patients receiving the radiopharmaceutical when the labeling efficiency was at least 85%. Occasional batches were milky in appearance, contained black particulate matter, were acidic, or contained a high percentage of unbound 99mTc activity. Although this kit makes 99mTc-human serum albumin accessible to most nuclear medicine facilities for general clinical use, an active quality control program is required prior to use in patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1244447

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  1 in total

1.  An evaluation of six kits of technetium 99m human serum albumin injection for cardiac blood pool imaging.

Authors:  A M Millar; W J Hannan; R P Sapru; A L Muir
Journal:  Eur J Nucl Med       Date:  1979-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.